Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-11-16

Clinical Trial Update: The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial on anticonvulsants for alcohol dependence with PTSD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Post Traumatic Stress Disorder | Phase 3 | Status: WITHDRAWN